John Anagnostis

John Anagnostis is a seasoned venture partner currently leading due diligence and investment strategies in the field of cancer therapeutics at CANCER FUND. With a successful track record of securing over $100MM for advanced R&D and managing investment raises exceeding $140MM, John has demonstrated expertise in sourcing and screening early-stage startups while facilitating partnerships with leading institutions. Previously, John served as a senior advisor at Focaccino, where strategic guidance on real estate site selection was provided, and as a managing director at Clear Access Capital, overseeing significant venture capital investments. Educational qualifications include an MBA from SDA Bocconi, a BA from Drew University, and various certifications from prestigious institutions such as The Wharton School and Columbia University.